AstraZeneca will acquire CinCor Pharma in a deal that aims to boost the British pharma giant’s cardiorenal pipeline, the company announced Monday. The $1.8 billion deal will give AstraZeneca CinCor’s ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted CardioRenal Systems breakthrough device designation for its RenalGuard Therapy, according to a ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Erica, I can't ...
Cardiorenal Systems Inc. has scored a U.S. FDA breakthrough device designation for technology to prevent patients undergoing cardiac surgery from developing acute kidney injury (AKI). AKI is reported ...
A panel of US-based experts in cardiology, nephrology, endocrinology, and primary care has prepared specific recommendations for early identification and intervention in obesity, diabetes, and other ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Chiadi E. Ndumele, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results